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Selective spinal anaesthesia (SSA) is a new regional 
anaesthesia technique in which minimal doses of 
intrathecal agents are used so that only the nerve 
root supplying the specific areas. This technique 
allows only the modalities that required to be anaes-
thetized are affected, dorsal column and motor 
function are mostly preserved such that patients are 
able to stand up and walk after the surgery. ‘Walk in, 
walk out’ spinal with an extremely low dose of local 
anaesthetics and opioids for daycare procedures 
created the concept of walking spinal anaesthesia.1
Hyperbaric bupivacaine injection is the 
commonly used drug for spinal anaesthesia, causes 
a long-lasting motor block, hypotension, and 
bradycardia which eliminate it as the drug of choice 
among all the local anaesthetics for daycare surger-
ies. Hence the quest is on for an alternative local 
anaesthetics and combinations which can produce 
spinal anaesthesia of relatively shorter duration 
with better haemodynamic stability. 
Ropivacaine and levobupivacaine are both pure 
S-enantiomers of bupivacaine. They are the two 
most recently introduced amide local anaesthet-
ics which possess a lower risk of cardiotoxicity 
compared with racemic bupivacaine.2 Due to their 
property of sensory-motor dissociation (ability to 
block sensory nerves to greater degree than motor 
nerve), these drugs allow a faster recovery of motor 
function and therefore are potentially useful agents 
for daycare anaesthesia.3
Fentanyl is commonly added to local anaes-
thetic solutions to improve anaesthesia and anal-
gesia allowing the use of very low doses of local 
anaesthetics, enabling the aim of minimal motor 
blockade, early mobilization and ambulation, with 
minimal side effects. In this study, we compared 
equipotent doses of ropivacaine and levobupiva-
caine with the addition of fentanyl for the intraop-
erative characteristics and recovery profile of these 
drugs as walking spinal anaesthesia for inguinal 
hernia repair.
PATIENTS AND METHODS
This prospective, double-blind, randomized, 
controlled study was conducted after obtaining 
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Background: Ropivacaine and levobupivacaine possess the property 
of sensory-motor dissociation. Hence these drugs allow a faster 
recovery of motor function and hence, these are potentially useful 
agents for walking spinal anaesthesia in daycare surgeries. 
Patients and Methods: This is a prospective, double-blind, 
randomized study involving 120 adult ASA 1 and 2 patients who 
were randomly allocated into two groups. Group R (n = 60) received 
7.5 mg 0.75% ropivacaine + 25 μg fentanyl + 1.5 ml sterile water. 
Group L (n = 60) received 5 mg 0.5% levobupivacaine + 25 μg 
fentanyl + 1.5 ml sterile water. Each solution was made to a total 
volume of 3 ml, administered intrathecally. Sensory and motor block 
characteristics, hemodynamic changes and postoperative recovery 
profile characteristics were noted. Paired/unpaired t-test and chi-
square test were used wherever applicable for statistical analysis using 
SPSS version 15.0. 
Results: Sensory block onset time and time to reach the maximal 
cephalic spread were comparable in both the groups, whereas 
time to the two-segment regression and time to first analgesic 
requirement were significantly shorter in group RF. Out of 60 patients 
in each group, 59 patients in group RF and 57 patients in group LF 
were MBS grade 5. Time to home discharge was also significantly 
shorter in group RF.
Conclusion: We concluded that both local anaesthetics could be used 
in the walking spinal technique; however, ropivacaine is preferred 
because of its favourable block characteristics and early ambulation 
time.
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Cite This Article: Singh, P., Kapur, A., Gupta, S.K. 2019. Comparative evaluation of low-dose levobupivacaine and ropivacaine in patients 
undergoing inguinal herniorrhaphy under walking spinal anaesthesia as daycare surgery. Bali Journal of Anesthesiology 3(2): 111-117. 
DOI:10.15562/bjoa.v3i2.166
Comparative evaluation of low-dose 
levobupivacaine and ropivacaine in patients 
undergoing inguinal herniorrhaphy under walking 
spinal anaesthesia as daycare surgery
Priyanka Singh,* Anu Kapur, Sanjay Kumar Gupta
112 Published by DiscoverSys | Bali Journal of Anesthesiology 2019; 3(2): 111-117 | doi: 10.15562/bjoa.v3i2.167
ORIGINAL ARTICLE
approval from the institutional ethical review 
board. After taking written informed consent, 
120  patients (ASA grade 1 and 2), between 
18-60 years of age, weighing 45-80 kg with a height 
between 150 to 180  cm, were randomly divided 
into two groups according to computer-generated 
random number list. The R group (n =60) received 
1 ml of 0.75% ropivacaine + 0.5 ml of 25 microgram 
fentanyl + 1.5 ml sterile water. The L group (n = 60) 
received 1 ml of 0.5% levobupivacaine + 0.5 ml of 
25 microgram fentanyl + 1.5 ml sterile water. Each 
of the solutions was made to a total volume of 3 ml.
All unwilling patients, known case of hypersen-
sitivity to local anaesthetics, patients with medical 
complications like raised intracranial tension, 
anaemia, heart disease, severe hypovolemia, shock, 
septicaemia, hypertension, patients with coagula-
tion disorders or on anticoagulant therapy, local 
infection at the proposed site of puncture for spinal 
anaesthesia and spinal deformities like kyphosco-
liosis and lordosis, were excluded from the study.
Study drug was prepared aseptically just before 
intrathecal injection by another anesthesiologist. 
Therefore the investigator was blinded to the drug 
administered for intrathecal injection. Patients 
were placed in the lateral decubitus position. The 
drug solution was administered intrathecally in 
L3-L4  space after local infiltration of 2% lidocaine, 
without any barbotage. Patients were placed supine 
immediately after the procedure with the table main-
tained horizontally. Time of intrathecal injection was 
noted in both the groups and was labelled as ‘0 min’ 
after intrathecal injection. Patients were given supple-
mentary oxygen at 2-4 litres/min by nasal prongs. 
Vital parameters were monitored at 5-minute 
intervals to the end of surgery. If systolic blood pres-
sure fell below 80 mmHg or 20% below the baseline 
(hypotension), injection mephentermine 3 mg intra-
venous was given. If the heart rate fell below 50/min 
or 20% below the baseline (bradycardia), injection 
atropine sulphate 0.6 mg intravenous was given.
Sensory block was assessed every two minutes 
till two consecutive readings of sensory block 
remain the same (i.e. when the highest cephalic 
spread of sensory block has occurred), after which 
it was assessed at ten-minute intervals till the end of 
surgery. The onset of sensory block at T10 was noted, 
and the surgeon was allowed to start the surgery. 
The modified Bromage scale was used to assess 
motor block by Breen et al.4 at the same interval of 
time as that of sensory block. The quality of surgical 
analgesia was evaluated by an anesthesiologist, the 
surgeon and the patient him/herself and was graded 
as: excellent (no discomfort and no supplementary 
drug required), good (mild discomfort but no anal-
gesia required), and poor (discomfort requiring 
rescue analgesia or general anaesthesia).
Quality of surgical field relaxation was classified 
as: excellent (complete relaxation), good (slight 
tightness but able to perform surgery), and poor 
(difficult to perform surgery). If adequate sensory 
and motor block was not attained even at twenty 
minutes after intrathecal injection of the drug, the 
patient was given general anaesthesia. Fentanyl 
2 µg/kg intravenously was given as rescue analgesia. 
All patients were monitored in the operative 
room for at least 60 minutes to keep a close watch 
on the hemodynamic and block characteristics, 
even if the surgery ended earlier. After comple-
tion of the surgery, the level of sensory block and 
motor block were recorded with the patient still 
on the operation table. This recording was labelled 
as the ‘immediate post-operative’ in the postoper-
ative period. The patients were shifted to the Post 
Anaesthesia Care Unit (PACU), and they were 
assessed every 30 minutes for motor block until they 
attain complete motor recovery. Sensory block was 
also assessed every 30 minutes until regression of 
sensory block to S2 dermatome. Patients were eval-
uated half-hourly by Post Anaesthesia Discharge 
Scoring System (PADSS)5 until a score of ≥9 was 
achieved, to check their readiness for discharge.
Time of request for the first analgesic was 
recorded. On the day after the surgery, patients were 
asked about any persistent symptoms like pain, 
nausea, vomiting, headache, backache, delayed 
voiding and neurologic symptoms such as tingling, 
numbness, and they were treated accordingly if any. 
They were also instructed to report if they suffered 
from any of the symptoms mentioned above within 
one week after the anaesthetic procedure. Follow up 
calls were made on the telephone to each patient.
In this study, the primary outcome variable was 
the time taken to ambulation. A sample size of 60 per 
group was calculated based on a difference in the 
time taken to ambulation between levobupivacaine 
and ropivacaine group, with a population variance of 
(50)2, a two-sided alpha of 0.05, and a power of 80%. 
Statistical Package for Social Sciences (SPSS) 
version 15.0 was used for statistical analysis. For 
comparing quantitative variables within each group 
across various follow-ups, we used paired t-test, 
and for comparing between the two groups, we 
have used the unpaired t-test. Qualitative variables 
between the two groups were compared using 
Chi-square/Fisher Exact test.  A two-sided p-value 
of <0.05 was considered statistically significant. 
RESULTS
Sensory block characteristics
As shown in Table 1, the sensory block onset 
at T10 was achieved in 6.33±1.37 minutes in 
Group L, compared to 5.92±1.48 minutes in 
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Group R (p =0.060). The mean time required for 
maximum cephalic spread of sensory block was 
14.33±2.56 minutes in Group L, and 13.53±2.88 min 
in Group R and the results were comparable 
(p=0.055).
The time to 2 segment regression of sensory 
block was significantly shorter in Group 
R  (86.75±16.30  minutes) compared to Group 
L  (p  <0.001). Hence, sensory block with ropiva-
caine was of quick onset and shorter duration than 
levobupivacaine. In Group L, two subjects failed to 
achieve sensory block at or above T10 dermatome 
and were given general anaesthesia. In comparison, 
all patients in Group R achieved sensory block at or 
above T10 dermatome (Figure 1). 
Motoric block characteristics
Out of 58 subjects in Group L, 55 (94.83%) showed 
minimal motor blockade, i.e. MBS-5, whereas, in 
Group R, 59 patients (98.33%) had Grade 5 motor 
blockade, as shown in Table 2 (p=0.047). Only 
three patients in Group L and one patient in Group 
R showed motor block. The difference in duration 
of complete motor block and the total duration of 
motor block was statistically significant (p <0.01).
Hemodynamic parameters
We found no significant differences in both groups 
in terms of intraoperative and postoperative heart 
rate, systolic and diastolic blood pressure, and 
mean blood pressure (Figure 2). Intraoperatively, 
only two subjects developed hypotension and one 
subject developed bradycardia. In the recovery 
room, one patient in Group L developed hypoten-
sion, but none of the patients in either group devel-
oped bradycardia. 
Postoperative recovery profile 
We assessed the efficacy of levobupivacaine and 
ropivacaine in ambulatory settings by using the 
PADSS score. A PADSS score of ≥9 was consid-
ered satisfactory for discharge. Due to surgical 
constraints (lower abdominal surgery), patients in 
our study were encouraged to ambulate only under 
supervision, preferably with some assistance, once 
all three criteria for ambulation fulfilled, i.e. the 
Table 1  Sensory block characteristics (in minutes)
Onset of sensory block Onset at T10 level




Levobupivacaine (mean±SD) 6.33±1.37 14.33±2.56 94.52±10.60
Ropivacaine (mean±SD) 5.92±1.48 13.53±2.88 86.75±16.30
p-value 0.060 0.055 <0.001
SD: standard deviation
Table 2 Motoric block characteristics
Group L Group R p-value
Maximum motoric block grading
Grade 2 1 (1.72) 0 (0) 0.158
Grade 3 2 (3.45) 1 (1.67) 0.279
Grade 4 0 (0) 0 (0) -
Grade 5 55 (94.83) 59 (98.33) 0.047
Onset to achieve maximum motoric block, 
minutes (mean±SD)
12.67±3.06 14.0±0.0 <0.01
Motoric block duration, minutes (mean±SD) 80.0±5.0 75.0±0.0 <0.01
SD: standard deviation
Table 4  Postoperative recovery profile characteristics (in minutes)
Group L Group R p
Regression to S2 211.62±23.35 188.10±23.80 <0.001
First rescue analgesic 170.34±22.58 145.23±22.34 <0.001
Time to ambulation 230.91±26.52 210.30±23.42 <0.001
Time to urination 291.62±24.27 270.30±21.50 <0.001
Time to achieve PADSS ≥9 332.19±26.73 317.82±18.38 <0.001
Data displayed in mean±SD; SD: standard deviation; PADSS: Post Anaesthesia Discharge Scoring System
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sensory block regression to S2 dermatome, abil-
ity to plantar flexion and sense of proprioception 
returning in the great toe.7
As our study includes the effectiveness of walk-
ing spinal anaesthesia, we looked for the ability to 
stand and walk (ASW) at the end of the surgery 
and at 60 minutes after intrathecal administration, 
whatever is later. As shown in Figure 3, the ASW 
at the end of operation among both the groups 
showed no statistical significance. 
As shown in Table 4, ropivacaine took less time 
for sensory block regression to S2 level compared 
to levobupivacaine (188.10±23.80 vs 211.62 ±23.35 
minutes, respectively). In our study, patients 
were given rescue analgesia when VAS score was 
recorded ≥3, and the time to first rescue analge-
sia was noted. Patients experienced pain in the 
recovery room, probably due to the regression 
of sensory block below the line of the surgi-
cal incision. Patients in Group R experienced 
postoperative pain requiring rescue analgesia 
earlier (145.23±22.34 minutes) than patients in 
Group L (170.34±22.58 minutes). 
Adverse events
In both groups, two patients developed hypoten-
sion, and one patient developed bradycardia. Three 
patients (5.00%) in the levobupivacaine group and 
four patients (6.67%) in the ropivacaine group 
complained of pruritus, which was managed with 
antihistamines. There was no statistically signif-
icant difference in regards to the intraoperative 
bradycardia and hypotension (Figure 4).
In the recovery room, one patient in levobu-
pivacaine developed hypotension, but none of 
the patients in either group developed bradycar-
dia. There was no need for sympathomimetics or 
anticholinergics in both the groups in the recov-
ery room. None of the patients in either group 
complained of persistence of these symptoms. In 
our study, we found no evidence of any transient 
neurologic symptoms with both levobupivacaine 
and ropivacaine. There was no episode of postop-
erative nausea, vomiting pruritus, and shivering 
in both groups. No complaints of low back pain 
or dysesthesias in the lower limbs and symptoms 
suggested of post-dural puncture headache (PDPH) 
were reported in the postoperative follow-up 
period.
Quality of analgesia and surgical field 
relaxation
Quality of analgesia was categorized excellent 
among 45 patients (75%) in Group L and 51 patients 
(85%) in Group R out of 60 patients (p >0.05). It 
was good in 13 patients (21.67%) in Group L and 
nine patients (15%) in Group RF. The quality of 
analgesia was categorized poor in only two patients 
in Group L; no patient showed poor quality of anal-
gesia in Group R (p >0.05).
Surgical field relaxation was excellent in 
45  patients in Group L and 47 patients in Group 
R. It was good in 13 patients in each group and 
poor in 2 patients in Group L (converted to general 
anaesthesia), and no patient showed poor quality of 
relaxation in Group R (p >0.05).
Figure 1  Distribution of maximum cephalic spread of sensory block
Figure 2  Intraoperative and postoperative changes in mean arterial pressure
Figure 3  The ability to stand and walk at the end of surgery in both groups
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DISCUSSION
Ambulatory surgery is rapidly growing worldwide 
due to recent advances in anaesthesia and surgical 
practices. The benefits of ambulation of patients 
at the earliest and discharge on the same day are, 
reduced risk of hospital-acquired infection, speed-
ier recovery, and better use of resources, shorter 
hospital stay, and hence better usage of high-cost 
operating rooms.6
To produce spinal anaesthesia for ambula-
tory inguinal hernia repair, increasing the dose 
of long-acting local anaesthetics will delay home 
readiness. Combining intrathecal opioids with local 
anaesthetics might be beneficial for achieving a 
higher sensory block and minimal motor blockade, 
without increasing the dose of local anaesthetics, 
and so early mobilisation. The use of low doses of 
local anaesthetics has allowed patients to achieve 
traditionally accepted discharge criteria.1
Nowadays, with shifting focus to daycare anaes-
thesia and ambulatory surgeries, more and more 
surgeries are being performed in a daycare setting. 
In that context, a study is needed to compare newer 
local anaesthetics, especially to achieve criteria’s of 
walking spinal anaesthesia successfully. There are 
many studies for walking epidural analgesia, but 
not many studies in the context of walking spinal 
anaesthesia and hence, till now a topic of research. 
More and more researches are required in support 
of this with various local anaesthetics so that it can 
be used daily in future. 
Ropivacaine was synthesised simultaneously 
with bupivacaine by Af Ekenstam almost 50 years 
ago and is first launched in 1996. It is the first pure 
S-enantiomer local anaesthetic to be clinically 
introduced. Several experimental and clinical 
studies confirm that ropivacaine has a lower and 
different toxicity profile compared to bupivacaine. 
The interpretation of a less intense motor block 
(differential motor block) and more rapid recovery 
of sensory and motor functions with intrathecal 
ropivacaine have been the subject of some contro-
versy. Some have argued that this is a specific drug 
effect of ropivacaine, demonstrating an increased 
separation of the sensory-motor blocking effects 
by its lower lipid solubility2 and therefore it blocks 
nerve fibres involved in pain transmission (Aδ and 
C fibres) to a greater degree than those controlling 
motor function (Aβ fibres). Others claim that the 
observed differences are merely due to reduced 
potency of ropivacaine compared with bupivacaine.7
Levobupivacaine is an amide, local anaesthetic, 
the pure S (-)-enantiomer of racemic bupivacaine. 
Its mechanism of action and pharmacodynamics 
are similar to those of bupivacaine. Its high lipid 
solubility makes it more potent than lower lipid-sol-
uble agent ropivacaine and results in a longer dura-
tion of action.
As we were using these drugs for ambula-
tory surgery, we chose a dose which ensured the 
adequate duration of analgesia above T10 without 
prolonging duration and degree of motor blockade. 
In the present study, we estimated the local analge-
sic dose to be 5 mg for levobupivacaine and 7.5 mg 
for ropivacaine. We added 25 mcg of Fentanyl in 
both the groups. The effect of adding fentanyl to 
both the groups is thought to be important for 
achieving anaesthesia with less motor blockade 
using a smaller amount of local anaesthetic and 
providing early postoperative ambulation.8
Moiza et al.9 reported that 8 mg levobupivacaine 
or 12 mg ropivacaine are acceptable alternatives to 
8 mg bupivacaine when limiting spinal anaesthesia 
at the operative side for inguinal repair. The use of 
a 1.5:1 equipotency ratio between ropivacaine and 
levobupivacaine resulted in a shorter duration of 
spinal anaesthesia with ropivacaine. 
Similar results have also been reported by 
Danelli et  al.10 The result of this study seem to 
confirm the validity of the 1:1.5 equipotency ratio 
between levobupivacaine and ropivacaine. For this 
reason, we considered both an equivalent and a 
supposed equipotent dose of 5 mg levobupivacaine 
as compared to 7.5 mg of ropivacaine.
Rate of onset and extent of the sensory block 
to pinprick showed no statistically significant 
difference between the two groups concerning the 
onset time to T10, the maximum extent of cephalic 
spread, and the time to maximum spread. These 
results are comparable with the results of a study 
done by Mantouvalou et al.11 where they found no 
significant differences in onset and time taken for 
the maximum level of the sensory block between 
levobupivacaine and ropivacaine group(p>0.05). 
Figure 4  Incidence of intraoperative and postoperative adverse events
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These results are also similar to the study conducted 
by Luck et al.12
There is a significant faster two-segment regres-
sion, and after that regression, to S2 level in the 
ropivacaine group as compared to the levobupi-
vacaine group. The results are in accordance with 
previous studies that also reported the time taken 
to two-segment regression shorter in ropivacaine 
compared to levobupivacaine.8,11,12
In this study, out of 60 patients, 55 patients in the 
levobupivacaine group as compared to 59 patients 
in the ropivacaine group showed minimal motor 
blockade. We believe that the plausible explanation 
of the absence of motor block in our study may be 
the small volume of local anaesthetics used intra-
thecally.8 Camorcia et  al.13 reported similar find-
ings, where they concluded that the relative motor 
blocking potency ratio of ropivacaine and levobu-
pivacaine was 0.83, showing significant trends for 
a greater motor block with levobupivacaine than 
ropivacaine. 
The total duration of motor block was also 
significantly shorter in the ropivacaine group 
(75  min) in comparison to the levobupivacaine 
group (p<0.01). Luck et  al.12 also found that the 
degree and duration of motor block were signifi-
cantly less in the ropivacaine group compared with 
the other two groups. Mantouvalou et  al.11 found 
the fact that regression of motor block from one 
stage of focus Bromage scale to the previous one 
was significantly faster in the ropivacaine group as 
compared to the levobupivacaine group. Similar 
results were found in this study. The values in our 
research are in line to a study by Casati et al.14 that 
reported faster complete regression of spinal anaes-
thesia in patients receiving ropivacaine.
In our study, the administration time of 
rescue analgesia was 170.34±22.58 minutes in the 
LF group while it was 145.23±22.34 minutes in the 
RF group (p <0.001). Camorcia et al.13 determined 
that the relative analgesic potency ratio for ropi-
vacaine to levobupivacaine was 0.80 (0.70-0.92), 
which supported our findings. A study conducted 
by Taspinar et al.8 also showed similar results.
The mean time for ambulation was shorter for 
the R group (210.30±23.42 minutes) than for the 
L group (230.91±26.52 minutes). Our study is in 
accordance with Luck et al.12 who calculated time 
to mobilisation between L and R to be statistically 
significant.
Urinary retention after spinal anaesthesia may 
delay home discharge. A long-lasting sensory 
block may affect the voiding capability, which 
requires regression of the sensory block to at least 
a dermatome level of S3 to obtain normal detrusor 
function.15 In our study, time to first micturition 
was longer (291.62±24.27 minutes) in Group L than 
Group R (270.30±21.50 minutes). Adjuvants such 
as fentanyl facilitate reductions in the dose of local 
anaesthetics and prolong sensory block without 
delaying time to void. Patients in Group R attained 
PADSS ≥9 (home readiness) earlier than patients in 
Group L, (p<0.001).
Cappelleri et al.16 in their study found that the 
resolution of spinal block and time to first void-
ing was significantly shorter with ropivacaine 
than levobupivacaine (p <0.05). Similarly, time to 
home discharge was also shorter with ropivacaine 
(p <0.05), supporting the findings in our study.
Our results showed that the patients were haemo-
dynamically stable in both the groups except a few 
episodes of bradycardia and hypotension. We have 
added opioids to the local anaesthetic solutions and 
applied them in over 15-20 seconds to minimize 
the intraoperative haemodynamic effects, and in 
this way, we can give a low dose of local anaesthetic 
with minimum hemodynamic side effects. 
There was no need for sympathomimetics or 
anticholinergics in both the groups in the recov-
ery room. None of these patients complained of 
pruritis postoperatively. In our study, we found no 
evidence of any transient neurologic symptoms 
with both levobupivacaine and ropivacaine. There 
were no episodes of postoperative nausea, vomiting 
or shivering in both the groups.
CONCLUSION
Ropivacaine produces a spinal block which has 
sensory block onset characteristics similar to equi-
potent doses of levobupivacaine, but with a less 
intense motor block. Both the sensory and motor 
blocks are also subject to a more rapid recovery 
with ropivacaine compared with levobupivacaine. 
In contrast, levobupivacaine has more analgesic 
potency as the administration time of rescue anal-
gesia for levobupivacaine is more as compared to 
ropivacaine. Secondly, levobupivacaine provides 
prolonged and more intense motor blockage as 
compared to ropivacaine. We suggest that both 
anaesthetics can be used in the walking spinal 
technique; however, ropivacaine may be preferred 
because of its block characteristics and early ambu-
lation time, for short procedures. Nowadays, with 
the focus shifting to daycare anaesthesia and ambu-
latory surgeries, further studies are required to 
compare these drugs in other doses with different 
adjuvants.
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